PER
Click for more information
0.00% 8.1¢ percheron therapeutics limited

Ann: ATL1102 Revised Plans accelerate reporting of unblinded data, page-5

  1. arjay
    3,547 Posts.
    lightbulb Created with Sketch. 771
    clock Created with Sketch.
    07/09/22
    09:22
    Post #: 63557716
    It's not Good ..It's AWESOME .

    I truly think this planning and work is from Dr CG..

    When you have an experience of CSL running 7 drugs all around the world...One drug is a piece of cake...

    Well done ANP management ....very proud holder and a fantastic move ...
    ANP Price at posting: 10.0¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 20  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

AUG Augustus sees imperial share rise on high-grade Cu and gold results at Ti-Tree
right-arrow Created with Sketch.
NEWS What matters for FY25: Investment; interest rates; inflation & elections
right-arrow Created with Sketch.
SKS SKS Technologies wins US$90M award to supply power to international hyperscale data centre in Melbourne
right-arrow Created with Sketch.
RNU Renascor wins a funding boost given it wants to produce a critical mineral – but $5M award pales in comparison to some
right-arrow Created with Sketch.
FWD Queensland's housing crisis an opportunity for ASX builder Fleetwood – and taxpayer cash a safe harbour from the storm
right-arrow Created with Sketch.
IMM Immutep reports strong response rate from immunotherapies treating carcinomas
right-arrow Created with Sketch.
watchlist Created with Sketch. Add PER (ASX) to my watchlist
(20min delay)
Last
8.1¢ 		Change
0.000(0.00%) 		Mkt cap ! $73.92M
Open High Low Value Volume
8.2¢ 8.2¢ 8.1¢ $47.41K 578.2K

Buyers (Bids)

No. Vol. Price($)
3 142694 8.1¢
 

Sellers (Offers)

Price($) Vol. No.
8.2¢ 104529 2
View Market Depth
Last trade - 14.00pm 12/07/2024 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.